Natural SEL1L variants rescue a model of NGLY1 deficiency and modify ERAD function and proteasome sensitivity. [PDF]
Tu'ifua TK, Chow CY.
europepmc +1 more source
Systemic gene therapy corrects the neurological phenotype in a mouse model of NGLY1 deficiency. [PDF]
Du A +9 more
europepmc +1 more source
Intranasal oxytocin suppresses seizure-like behaviors in a mouse model of NGLY1 deficiency. [PDF]
Makita Y +4 more
europepmc +1 more source
Orthopaedic phenotyping of NGLY1 deficiency using an international, family-led disease registry. [PDF]
Cahan EM, Frick SL.
europepmc +1 more source
Defects in the Neuroendocrine Axis Contribute to Global Development Delay in a Drosophila Model of NGLY1 Deficiency. [PDF]
Rodriguez TP +5 more
europepmc +1 more source
Transiently elevated plasma methionine, S-adenosylmethionine and S-adenosylhomocysteine: Unreported laboratory findings in a patient with NGLY1 deficiency, a congenital disorder of deglycosylation. [PDF]
Chang CA +4 more
europepmc +1 more source
Drug screens of NGLY1 deficiency in worm and fly models reveal catecholamine, NRF2 and anti-inflammatory-pathway activation as potential clinical approaches. [PDF]
Iyer S +8 more
europepmc +1 more source
Progressive neurodegeneration, motor decline, and premature mortality in aging Ngly1 deficient rats. [PDF]
Zhu L +3 more
europepmc +1 more source
NGLY1 as an Emerging Critical Modulator for Neurodevelopment and Pathogenesis in the Brain. [PDF]
Zhang H, Xue H, Wang YC, Liu Y.
europepmc +1 more source
Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation. [PDF]
Wang R +23 more
europepmc +1 more source

